Hints and tips:
Related Special Reports
...UK ministers are hoping to secure a major new vaccines investment by AstraZeneca with a possible state aid package worth tens of millions of pounds, in a deal that would deliver a big boost to Britain’s...
...GSK is on the hunt for deals in China after the UK drugmaker rebuilt a “very strong” relationship with the government and local companies since a corruption scandal a decade ago....
...that Hunt was looking at the idea as one of a range of last-minute revenue-raising options, but said the chancellor would only act if official forecasts deteriorated over the next few days and further limited...
...The chancellor said that AstraZeneca would invest £650mn in the UK to expand its manufacturing, after the government had encouraged the pharmaceutical company to increase its UK investment....
...help the UK company to develop a portfolio of radioconjugate drugs....
...AstraZeneca’s jab developed with Oxford university was widely used across the world, but sales fell more than 99 per cent to just $12mn in 2023....
...These data reinforce that message,” said Susan Galbraith, executive vice-president of oncology R&D at AstraZeneca....
...Muir had worked at AstraZeneca, which has more than 8,700 employees in the UK, since 1998....
...GSK’s chief commercial officer Luke Miels told the Financial Times this month that the UK pharmaceutical company was hunting for deals in China, having rebuilt a “very strong relationship” with the government...
...The deal is expected to close in the first quarter of next year, AstraZeneca said....
...If found liable, any damages would be covered by a UK government vaccine damage payment scheme. AstraZeneca said the defendant’s case that the vaccine was defective was “confused” and “wrong in law”....
...The agreement is part of AstraZeneca’s ambitious plans to replace traditional chemotherapy with a new generation of targeted drugs....
...Daiichi Sankyo, which developed the drug with AstraZeneca and leads on marketing of the product in the UK, said it was “extremely disappointed by the decision”....
...Galbraith did not comment on whether AstraZeneca had bid to partner on the next drugs in the pipeline....
...Wegovy’s official list price in the UK is about £175.80 per pack of 2.4mg doses — about a sixth of the US list price, though health systems and insurers, including the NHS, negotiate confidential discounts...
...The UK company reached the settlement without providing any details....
...There has been growing frustration in Tory circles that the independent UK fiscal watchdog has the chancellor in a “headlock” and that its deteriorating economic forecasts in recent weeks have limited the...
...With the NHS and a strong life sciences sector, the UK could become a global vaccine superpower....
...Big share price moves in Europe today include UK electronics retailer Currys, Anglo-Swedish pharma group AstraZeneca and British mining group Anglo American....
...“The current market structure is holding the UK back, which is not good for customers or competition,” Robert Finnegan, chief executive of Three UK, said in a statement....
...AstraZeneca has become the latest large pharmaceutical company to sue the US over a law that allows the government to negotiate some drug prices for the first time....
...Under the reforms, Medicare, the US taxpayer-funded healthcare scheme for retirees, is allowed to negotiate prices for a limited number of branded medicines....
...But that limited concession to the energy sector did little to assuage anger in the industry over Starmer’s plans to instead extend the lifetime of the levy by two years until 2029....
...UK public sector borrowing was higher than expected in November, underscoring the limited scope for chancellor Jeremy Hunt to make tax cuts in the run-up to the general election....
...De Montessus was the highest-paid chief executive in the FTSE 100 in 2021, earning $22.7mn, despite Endeavour being a fraction of the size of the London market’s biggest companies such as Shell and AstraZeneca...
International Edition